These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 25323660)

  • 21. Glucocorticoid receptor polymorphisms modulate cardiometabolic risk factors in patients in long-term remission of Cushing's syndrome.
    Roerink SH; Wagenmakers MA; Smit JW; van Rossum EF; Netea-Maier RT; Plantinga TS; Hermus AR
    Endocrine; 2016 Jul; 53(1):63-70. PubMed ID: 26873309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Body Composition is Different After Surgical or Pharmacological Remission of Cushing's Syndrome: A Prospective DXA Study.
    Ceccato F; Boccato M; Zilio M; Barbot M; Frigo AC; Luisetto G; Boscaro M; Scaroni C; Camozzi V
    Horm Metab Res; 2017 Sep; 49(9):660-666. PubMed ID: 28718178
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Body composition and cardiovascular risk markers after remission of Cushing's disease: a prospective study using whole-body MRI.
    Geer EB; Shen W; Strohmayer E; Post KD; Freda PU
    J Clin Endocrinol Metab; 2012 May; 97(5):1702-11. PubMed ID: 22419708
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiovascular risk and white matter lesions after endocrine control of Cushing's syndrome.
    Santos A; Resmini E; Gómez-Ansón B; Crespo I; Granell E; Valassi E; Pires P; Vives-Gilabert Y; Martínez-Momblán MA; de Juan M; Mataró M; Webb SM
    Eur J Endocrinol; 2015 Dec; 173(6):765-75. PubMed ID: 26497546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interleukin-1 receptor antagonist is associated with fat distribution in endogenous Cushing's syndrome: a longitudinal study.
    Ueland T; Kristo C; Godang K; Aukrust P; Bollerslev J
    J Clin Endocrinol Metab; 2003 Apr; 88(4):1492-6. PubMed ID: 12679428
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regional fat distribution and cardiometabolic risk in healthy postmenopausal women.
    Peppa M; Koliaki C; Hadjidakis DI; Garoflos E; Papaefstathiou A; Katsilambros N; Raptis SA; Dimitriadis GD
    Eur J Intern Med; 2013 Dec; 24(8):824-31. PubMed ID: 24169066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating fibroblast growth factor-23 is associated with fat mass and dyslipidemia in two independent cohorts of elderly individuals.
    Mirza MA; Alsiö J; Hammarstedt A; Erben RG; Michaëlsson K; Tivesten A; Marsell R; Orwoll E; Karlsson MK; Ljunggren O; Mellström D; Lind L; Ohlsson C; Larsson TE
    Arterioscler Thromb Vasc Biol; 2011 Jan; 31(1):219-27. PubMed ID: 20966399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thigh Muscle Fat Infiltration Is Associated With Impaired Physical Performance Despite Remission in Cushing's Syndrome.
    Martel-Duguech L; Alonso-Jiménez A; Bascuñana H; Díaz-Manera J; Llauger J; Nuñez-Peralta C; Biagetti B; Montesinos P; Webb SM; Valassi E
    J Clin Endocrinol Metab; 2020 May; 105(5):. PubMed ID: 31912154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vascular Health in Patients in Remission of Cushing's Syndrome Is Comparable With That in BMI-Matched Controls.
    Wagenmakers MA; Roerink SH; Schreuder TH; Plantinga TS; Holewijn S; Thijssen DH; Smit JW; Rongen GA; Pereira AM; Wagenmakers AJ; Netea-Maier RT; Hermus AR
    J Clin Endocrinol Metab; 2016 Nov; 101(11):4142-4150. PubMed ID: 27552540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Persistence of increased cardiovascular risk in patients with Cushing's disease after five years of successful cure.
    Colao A; Pivonello R; Spiezia S; Faggiano A; Ferone D; Filippella M; Marzullo P; Cerbone G; Siciliani M; Lombardi G
    J Clin Endocrinol Metab; 1999 Aug; 84(8):2664-72. PubMed ID: 10443657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transsphenoidal microsurgery for Cushing's disease: initial outcome and long-term results.
    Hammer GD; Tyrrell JB; Lamborn KR; Applebury CB; Hannegan ET; Bell S; Rahl R; Lu A; Wilson CB
    J Clin Endocrinol Metab; 2004 Dec; 89(12):6348-57. PubMed ID: 15579802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The metabolic syndrome and cardiovascular risk in Cushing's syndrome.
    Pivonello R; Faggiano A; Lombardi G; Colao A
    Endocrinol Metab Clin North Am; 2005 Jun; 34(2):327-39, viii. PubMed ID: 15850845
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased Adipocyte Size, Macrophage Infiltration, and Adverse Local Adipokine Profile in Perirenal Fat in Cushing's Syndrome.
    Roerink SHPP; Wagenmakers MAEM; Langenhuijsen JF; Ballak DB; Rooijackers HMM; d'Ancona FC; van Dielen FM; Smit JWA; Plantinga TS; Netea-Maier RT; Hermus ARMM
    Obesity (Silver Spring); 2017 Aug; 25(8):1369-1374. PubMed ID: 28594137
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating resistin levels are not associated with fat redistribution, insulin resistance, or metabolic profile in patients with the highly active antiretroviral therapy-induced metabolic syndrome.
    Barb D; Wadhwa SG; Kratzsch J; Gavrila A; Chan JL; Williams CJ; Karchmer AW; Mantzoros CS
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5324-8. PubMed ID: 15956078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deleterious effects of glucocorticoid replacement on bone in women after long-term remission of Cushing's syndrome.
    Barahona MJ; Sucunza N; Resmini E; Fernández-Real JM; Ricart W; Moreno-Navarrete JM; Puig T; Wägner AM; Rodriguez-Espinosa J; Farrerons J; Webb SM
    J Bone Miner Res; 2009 Nov; 24(11):1841-6. PubMed ID: 19453254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Common genetic variants in the glucocorticoid receptor and the 11β-hydroxysteroid dehydrogenase type 1 genes influence long-term cognitive impairments in patients with Cushing's syndrome in remission.
    Ragnarsson O; Glad CA; Berglund P; Bergthorsdottir R; Eder DN; Johannsson G
    J Clin Endocrinol Metab; 2014 Sep; 99(9):E1803-7. PubMed ID: 24915124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estimation of body fat and lean tissue distribution by dual energy X-ray absorptiometry and abdominal body fat evaluation by computed tomography in Cushing's disease.
    Wajchenberg BL; Bosco A; Marone MM; Levin S; Rocha M; Lerário AC; Nery M; Goldman J; Liberman B
    J Clin Endocrinol Metab; 1995 Sep; 80(9):2791-4. PubMed ID: 7673425
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship of adiposity with arterial stiffness as mediated by adiponectin in older men and women: the Hoorn Study.
    Snijder MB; Flyvbjerg A; Stehouwer CD; Frystyk J; Henry RM; Seidell JC; Heine RJ; Dekker JM
    Eur J Endocrinol; 2009 Mar; 160(3):387-95. PubMed ID: 19095778
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Obesity and body fat classification in the metabolic syndrome: impact on cardiometabolic risk metabotype.
    Phillips CM; Tierney AC; Perez-Martinez P; Defoort C; Blaak EE; Gjelstad IM; Lopez-Miranda J; Kiec-Klimczak M; Malczewska-Malec M; Drevon CA; Hall W; Lovegrove JA; Karlstrom B; Risérus U; Roche HM
    Obesity (Silver Spring); 2013 Jan; 21(1):E154-61. PubMed ID: 23505198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Body-mass index, abdominal adiposity, and cardiovascular risk.
    Gonçalves FB; Koek M; Verhagen HJ; Niessen WJ; Poldermans D
    Lancet; 2011 Jul; 378(9787):227; author reply 228. PubMed ID: 21763933
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.